600380 健康元
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入3,721,498-8.99%15,215,73915,619,48016,646,35017,142,753
减:营业总成本2,735,585-8.60%11,890,93711,986,20213,123,51613,784,938
    其中:营业成本1,369,915-12.10%5,714,3235,827,8536,298,4666,252,265
               财务费用(14,211)-83.42%(308,783)(301,975)(404,841)(352,447)
               资产减值损失(721)-88.65%(120,790)(293,144)(312,370)(142,628)
公允价值变动收益(17,658)-1,132.95%19,494(17,496)(25,420)(76,263)
投资收益49,031203.87%71,49264,37179,47555,973
    其中:对联营企业和合营企业的投资收益38,16392.59%60,61227,08072,79470,578
营业利润1,040,370-9.69%3,465,9293,616,2843,506,5653,479,936
利润总额1,036,838-9.93%3,366,3083,574,8873,465,5553,456,105
减:所得税费用153,387-19.27%501,279592,141614,536561,797
净利润883,451-8.08%2,865,0292,982,7462,851,0192,894,308
减:非控股权益468,479-10.82%1,529,4811,596,1761,408,2391,391,531
股东净利润414,971-4.78%1,335,5481,386,5701,442,7801,502,777

市场价值指针
每股收益 (元) *0.2300.00%0.7300.7400.7600.793
每股派息 (元) *----0.2200.2000.1800.180
每股净资产 (元) *8.5336.60%8.2977.7557.3746.802
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容